POSTED BY Sardiaa Leney Since the passage of the Hatch-Waxman provisions 30 years ago, a fairly orderly market in generic small molecule drugs has developed, reducing the cost of some of the commonest medicines to a fraction of their pre-competition price points.  Biologics medicines are another matter.   Biologics are drugs comprising molecules so complex that… Read More Grandma Could Afford Her Arthritis Medication…If She Lived In Europe